Updated:
Smiths Medical Group Limited
Smiths Medical Group Limited is a Minneapolis-based entity with a name that evokes the global medical-device manufacturer Smiths Medical, a business that...
Smiths Medical Group Limited
Smiths Medical Group Limited is a Minneapolis-based entity with a name that evokes the global medical-device manufacturer Smiths Medical, a business that was part of the UK-listed Smiths Group until its $2.3 billion sale to ICU Medical in January 2022 (per Reuters, 2021). The corporate record shows no public linkage between this Minnesota-registered limited company and the divested Smiths Medical assets, nor any disclosed connection to the Smiths Group plc that previously owned them. No founding year, named principals, or operational history appears in any public filing or commercial registry accessible as of mid-2026. The firm's stated website at smiths-medical.com resolves to a domain that ICU Medical now controls for its Smiths Medical product line — infusion pumps, vascular access devices, and respiratory-care equipment. The domain serves as a product catalog and customer support portal for the medical-device business, not an investment-entity homepage. No separate investor-relations site, limited-partner portal, or portfolio disclosure exists for Smiths Medical Group Limited as a distinct financial entity. The Minneapolis address aligns with the US operational headquarters of Smiths Medical before the ICU Medical acquisition, but the corporate structure separating the medical-device operating company from this limited company remains opaque. No AUM, deployment figures, investment professionals, or fund vehicles are disclosed in any public source. The entity does not appear in SEC filings as a registered investment adviser, nor in FINRA records, nor in Minnesota state securities-registration databases under this name. It maintains no LinkedIn presence, no press mentions post-dating the ICU Medical transaction, and no regulatory disclosures that would confirm active investment operations. If it once served as a holding vehicle for legacy Smiths Medical intellectual property or royalty streams, that structure dissolved or went dormant with the 2022 divestiture. What distinguishes Smiths Medical Group Limited is the gap between its corporate name and any verifiable investment activity — a rare case where the name implies a substantive operating history that public records do not support. For allocators, the structural question is whether this represents a dormant legacy entity from the pre-divestiture Smiths Group corporate tree or an unregistered family vehicle using a familiar name without connection to the medical-device assets. Either scenario makes due diligence on the entity impossible without direct outreach.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Frequently asked questions
Is Smiths Medical Group Limited connected to the Smiths Medical device business sold to ICU Medical?
No public connection exists. Smiths Medical — the infusion-pump and respiratory-device manufacturer — was sold by Smiths Group plc to ICU Medical for $2.3 billion in January 2022 (per Reuters, 2021). The domain smiths-medical.com now belongs to ICU Medical's product division. The limited company registered in Minneapolis shares the name but appears in no corporate disclosures linking it to the divested assets or the parent Smiths Group.
Does Smiths Medical Group Limited manage outside capital or disclose an AUM?
No. The entity discloses no assets under management, no investment team, no portfolio holdings, and no fund vehicles in any public filing. It does not appear as a registered investment adviser with the SEC or Minnesota state securities regulators. Allocators should treat it as having no verifiable investment operations absent direct confirmation from principals.
Who runs Smiths Medical Group Limited?
No named principals are publicly identified for Smiths Medical Group Limited. Minnesota business-registry records may list a registered agent or manager, but no individual has been publicly named as an investment lead, managing member, or portfolio manager in any accessible source. This opacity is consistent with dormant holding vehicles or unregistered private investment entities.
What investment strategy does Smiths Medical Group Limited pursue?
There is no publicly disclosed investment strategy. The entity maintains no website describing asset-class preferences, stage focus, or geographic mandate. Without direct outreach to confirmed principals, no allocation decision can be supported — the entity has no verifiable track record, sector exposure, or transactional history in the public domain.
Why does the firm use the Smiths Medical name if it may be unrelated to the medical-device company?
The name likely originates from the corporate structure of Smiths Group plc before the 2022 divestiture. Multinationals often maintain legacy holding companies, IP-holding entities, or regional subsidiaries that survive corporate transactions. Smiths Medical Group Limited may be a dormant Minnesota entity from the pre-sale structure — or an unrelated registration. Without corporate records confirming the linkage, the name is the only public signal and it provides no investment-relevant information.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: